Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Analysts

Establishment Labs Holdings Inc. (NASDAQ:ESTA) has been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $56.50.

A number of equities analysts have weighed in on ESTA shares. Needham & Company LLC reissued a “buy” rating and set a $48.00 price objective on shares of Establishment Labs in a research note on Friday, June 13th. Citigroup boosted their price objective on Establishment Labs from $38.00 to $47.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 9th. Mizuho boosted their price objective on Establishment Labs from $58.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 16th. Wall Street Zen raised Establishment Labs from a “sell” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Canaccord Genuity Group started coverage on Establishment Labs in a research note on Wednesday, August 20th. They set a “buy” rating and a $60.00 price objective on the stock.

Hedge Funds Weigh In On Establishment Labs

Large investors have recently modified their holdings of the business. ANTIPODES PARTNERS Ltd acquired a new position in shares of Establishment Labs in the 1st quarter valued at $81,000. Osaic Holdings Inc. lifted its stake in shares of Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after purchasing an additional 1,800 shares during the last quarter. CWM LLC lifted its stake in shares of Establishment Labs by 45.9% in the 2nd quarter. CWM LLC now owns 2,182 shares of the company’s stock valued at $93,000 after purchasing an additional 686 shares during the last quarter. Elevation Point Wealth Partners LLC acquired a new position in shares of Establishment Labs in the 1st quarter valued at $207,000. Finally, Patriot Financial Group Insurance Agency LLC acquired a new position in shares of Establishment Labs in the 1st quarter valued at $234,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Stock Performance

Shares of NASDAQ:ESTA opened at $41.43 on Monday. The company has a debt-to-equity ratio of 9.71, a current ratio of 2.84 and a quick ratio of 1.67. The business’s 50 day moving average price is $39.81 and its 200-day moving average price is $38.03. The firm has a market capitalization of $1.20 billion, a PE ratio of -13.58 and a beta of 0.85. Establishment Labs has a 1 year low of $26.56 and a 1 year high of $50.85.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.03). The firm had revenue of $51.30 million during the quarter, compared to analyst estimates of $50.80 million. Establishment Labs had a negative return on equity of 224.34% and a negative net margin of 49.89%.The business’s revenue was up 16.1% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.62) earnings per share. Establishment Labs has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Establishment Labs will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.